Dirk Arnold

33.3k total citations · 14 hit papers
271 papers, 17.0k citations indexed

About

Dirk Arnold is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Dirk Arnold has authored 271 papers receiving a total of 17.0k indexed citations (citations by other indexed papers that have themselves been cited), including 189 papers in Oncology, 122 papers in Pulmonary and Respiratory Medicine and 87 papers in Surgery. Recurrent topics in Dirk Arnold's work include Colorectal Cancer Treatments and Studies (156 papers), Gastric Cancer Management and Outcomes (89 papers) and Cancer Treatment and Pharmacology (54 papers). Dirk Arnold is often cited by papers focused on Colorectal Cancer Treatments and Studies (156 papers), Gastric Cancer Management and Outcomes (89 papers) and Cancer Treatment and Pharmacology (54 papers). Dirk Arnold collaborates with scholars based in Germany, France and United States. Dirk Arnold's co-authors include Andrés Cervantes, Emmanuel Tiret, Bernard Nordlinger, Bengt Glimelius, Eric Van Cutsem, Rob Glynne‐Jones, Karin Haustermans, David Cunningham, Marcel Verheij and William Allum and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Dirk Arnold

252 papers receiving 16.8k citations

Hit Papers

Rectal cancer: ESMO Clinical Practice Guidelines for diag... 2012 2026 2016 2021 2013 2017 2013 2016 2015 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    2013 1.4k citations Emmanuel Tiret, Andrés Cervantes et al. Annals of Oncology profile →
  2. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    2017 1.3k citations Rob Glynne‐Jones, Lucjan Wyrwicz et al. Annals of Oncology profile →
  3. Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    2013 1.1k citations Andrés Cervantes, Dirk Arnold et al. Annals of Oncology profile →
  4. Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    2016 1.1k citations Andrés Cervantes, Dirk Arnold et al. Annals of Oncology profile →
  5. Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    2015 941 citations Michel Ducreux, Dirk Arnold et al. Annals of Oncology profile →
  6. Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    2014 880 citations Eric Van Cutsem, Andrés Cervantes et al. Annals of Oncology profile →
  7. Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial
    2012 829 citations Dirk Arnold, Pia Österlund et al. profile →
  8. Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
    2022 774 citations Andrés Cervantes, R. Adam et al. Annals of Oncology profile →
  9. Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    2016 757 citations Dirk Arnold et al. Annals of Oncology profile →
  10. Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials
    2017 554 citations Dirk Arnold, Jean-Yves Douillard et al. Annals of Oncology profile →
  11. Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    2016 471 citations Juan W. Valle, Ivan Borbath et al. Annals of Oncology profile →
  12. Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up
    2014 386 citations Rob Glynne‐Jones, Andrés Cervantes et al. profile →
  13. Updated treatment recommendations for hepatocellular carcinoma (HCC) from the ESMO Clinical Practice Guidelines
    2021 306 citations Arndt Vogel, Andrés Cervantes et al. Annals of Oncology profile →
  14. Anal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆
    2021 112 citations Sheela Rao, Marianne G. Guren et al. Annals of Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dirk Arnold Germany 47 11.4k 6.9k 6.7k 2.4k 1.9k 271 17.0k
Kenichi Sugihara Japan 72 10.9k 1.0× 7.7k 1.1× 6.8k 1.0× 2.5k 1.1× 1.2k 0.6× 508 17.6k
Ian Chau United Kingdom 56 13.1k 1.2× 5.4k 0.8× 7.2k 1.1× 2.6k 1.1× 3.2k 1.7× 473 18.8k
Valérie Boige France 63 9.5k 0.8× 5.7k 0.8× 6.2k 0.9× 2.4k 1.0× 3.9k 2.0× 287 17.6k
Philip B. Paty United States 80 13.2k 1.2× 9.2k 1.3× 3.7k 0.6× 2.2k 0.9× 2.1k 1.1× 303 18.0k
Martin R. Weiser United States 70 11.0k 1.0× 7.7k 1.1× 3.4k 0.5× 2.4k 1.0× 1.1k 0.6× 355 15.2k
Stefano Cascinu Italy 63 11.2k 1.0× 3.4k 0.5× 7.3k 1.1× 2.6k 1.1× 1.7k 0.9× 648 18.3k
Christian Wittekind Germany 59 10.7k 0.9× 9.4k 1.4× 4.5k 0.7× 1.2k 0.5× 1.2k 0.6× 218 17.3k
Christophe Louvet France 54 14.9k 1.3× 4.2k 0.6× 6.1k 0.9× 2.4k 1.0× 3.6k 1.9× 278 17.8k
Michael J. Overman United States 58 11.2k 1.0× 3.9k 0.6× 3.9k 0.6× 4.1k 1.7× 2.3k 1.2× 447 16.5k
Christopher G. Willett United States 71 9.6k 0.8× 9.1k 1.3× 7.7k 1.2× 1.1k 0.5× 721 0.4× 308 17.4k

Countries citing papers authored by Dirk Arnold

Since Specialization
Citations

This map shows the geographic impact of Dirk Arnold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk Arnold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk Arnold more than expected).

Fields of papers citing papers by Dirk Arnold

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dirk Arnold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk Arnold. The network helps show where Dirk Arnold may publish in the future.

Co-authorship network of co-authors of Dirk Arnold

This figure shows the co-authorship network connecting the top 25 collaborators of Dirk Arnold. A scholar is included among the top collaborators of Dirk Arnold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dirk Arnold. Dirk Arnold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Eric Xueyu, Rozita Abdul Malik, Yu‐Li Su, et al.. (2026). Amivantamab plus FOLFOX or FOLFIRI in RAS/BRAF wild-type metastatic colorectal cancer: Long-term follow-up from the phase 1b/2 OrigAMI-1 study.. Journal of Clinical Oncology. 44(2_suppl). 166–166.
2.
Ronot, Maxime, Romaric Loffroy, Dirk Arnold, et al.. (2025). Transarterial Radioembolisation with Y90 Resin Microspheres and the Effect of Reimbursement Criteria in France: Final Results of the CIRT-FR Prospective Observational Study. CardioVascular and Interventional Radiology. 48(2). 205–220. 3 indexed citations
3.
4.
5.
6.
7.
8.
Franco, Pierfrancesco, Eva Segelov, Anders Johnsson, et al.. (2022). A Machine-Learning-Based Bibliometric Analysis of the Scientific Literature on Anal Cancer. Cancers. 14(7). 1697–1697. 10 indexed citations
9.
Cervantes, Andrés, R. Adam, Susana Roselló, et al.. (2022). Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Annals of Oncology. 34(1). 10–32. 774 indexed citations breakdown →
10.
Schaefer, Niklaus, Gerd Grözinger, Maciej Pech, et al.. (2022). Prognostic Factors for Effectiveness Outcomes After Transarterial Radioembolization in Metastatic Colorectal Cancer: Results From the Multicentre Observational Study CIRT. Clinical Colorectal Cancer. 21(4). 285–296. 7 indexed citations
11.
Arnold, Dirk, et al.. (2022). Sonographic changes in denervated facial muscles trough long-term home-based surface electrostimulation. Laryngo-Rhino-Otologie. 101(S 02). S240–S241.
12.
Schmoll, Hans‐Joachim, Dirk Arnold, Aimery de Gramont, et al.. (2018). MODUL—a multicenter randomized clinical trial of biomarker-driven maintenance therapy following first-line standard induction treatment of metastatic colorectal cancer: an adaptable signal-seeking approach. Journal of Cancer Research and Clinical Oncology. 144(6). 1197–1204. 23 indexed citations
13.
14.
Glynne‐Jones, Rob, Lucjan Wyrwicz, Emmanuel Tiret, et al.. (2017). Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology. 28(suppl_4). iv22–iv40. 1290 indexed citations breakdown →
15.
Tabernero, Josep, Malvika Vyas, Rosa Giuliani, et al.. (2016). Biosimilars: a position paper of the European Society for Medical Oncology, with particular reference to oncology prescribers. ESMO Open. 1(6). e000142–e000142. 88 indexed citations
16.
Valle, Juan W., Ivan Borbath, Shahid A. Khan, et al.. (2016). Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology. 27(suppl 5). v28–v37. 471 indexed citations breakdown →
17.
Stein, Alexander, Volker Petersen, Jörg Seraphin, et al.. (2014). Bevacizumab plus chemotherapy as first-line treatment for patients with metastatic colorectal cancer: Results from a large German community-based observational cohort study. Acta Oncologica. 54(2). 171–178. 12 indexed citations
18.
Piso, Pompiliu, Dirk Arnold, & Gabriel Glockzin. (2014). Challenges in the multidisciplinary management of stage IV colon and rectal cancer. Expert Review of Gastroenterology & Hepatology. 9(3). 317–326. 8 indexed citations
19.
20.
Arnold, Dirk & Ulrich Hacker. (2007). Palliative Chemotherapie des Kolonkarzinoms. Oncology Research and Treatment. 30(2). 13–17. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kenichi Sugihara Breakdown of academic impact, for papers by Ian Chau Breakdown of academic impact, for papers by Valérie Boige Breakdown of academic impact, for papers by Philip B. Paty Breakdown of academic impact, for papers by Martin R. Weiser Breakdown of academic impact, for papers by Stefano Cascinu Breakdown of academic impact, for papers by Christian Wittekind Breakdown of academic impact, for papers by Christophe Louvet Breakdown of academic impact, for papers by Michael J. Overman Breakdown of academic impact, for papers by Christopher G. Willett
Rankless by CCL
2026